Breaking News
-
Bio News | Industry News | Promotions & Moves
Aclaris Therapeutics Announces Key Hires
Dr. David Gordon joins the company as chief medical officer, and Dr. Elaine Morefield joins as director of product quality06.15.18
-
Bio News | Collaborations & Alliances | Industry News
Recipharm, SERB Enter Agreement
For a divestment of its rights to its potassium iodide product ThyroSafe® except for the US territory.06.15.18
-
Industry News | Laboratory Testing
ACM Global Labs Acquires ABS Labs
Expands collection of domestic and international labs focused on bioanalytical, toxicology and central lab testing06.15.18
-
Drug Development | Drug Discovery | Industry News | R&D
BridgeBio Launches CoA Therapeutics
To develop novel small-molecules designed to increase CoA levels in genetic disorders where CoA deficiency is implicated06.14.18
-
Breaking News | Cold Chain Management | Industry News | Logistics | Packaging & Tracking | Supply Chain
Marken Moves Chicago Ops To New Full Service Location
Logistics hub relocated and expanded to serve local clinical trial clients06.14.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Artelo, Syngene Enter Partnership
For the drug discovery and clinical development of ART27.13, Artelo's Phase 2 ready, high-potency dual cannabinoid agonist06.14.18
-
Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
LakePharma, Harbour Antibodies Form Discovery Partnership
Agreement provides access to H2L2 platform use with LakePharma's discovery and develop-ment services06.14.18
-
Drug Development | Drug Discovery | Facilities | Industry News
Eisai Launches Dementia Discovery Center
Over $100 million committed as an initial investment to establish the new 50,000 sq. ft. discovery center in Cambridge, MA06.14.18
-
Breaking News | Industry News | Promotions & Moves | Serialization
PCI Names VP of Global Operations Strategy and Program Mgmt.
Chris Blanton to support ongoing PCI Pharma Services growth and expansion initiatives06.14.18
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Brammer Bio, Sarepta Enter Long-term Mfg. Tie-up
Partnership will provide commercial supply for a potential micro-dystrophin gene therapy product launch06.14.18
-
APIs | Breaking News | Collaborations & Alliances | Industry News | Process Validation | Regulatory Affairs
WuXi STA Enables Ascletis to Receive NDA Approval from China FDA for Ganovo
Is first CDMO to support the approval of an innovative drug in China through the MAH pilot program06.14.18
-
Promotions & Moves
Catalent Appoints Clinical Supply Services President
Hegwood to head up Clinical Supply Services Operations06.13.18
-
cGMP Manufacture | Drug Delivery | Industry News
Recipharm Acquires Sanofi’s UK CMO Biz
Expands inhalation capabilities with commercial drug product manufacturing06.13.18
-
Industry News | Promotions & Moves | Toxicology
Sinclair Research Announces Executive Appointment
Dr. Jeffrey Klein joins the company as director of toxicology and dermatology, a newly created position06.13.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Alcami Extends Workbench Laboratory Services Program
To support the ongoing manufacturing and development of ZILRETTA for Flexion Therapeutics06.13.18
-
Bioassay Development | Breaking News | Drug Discovery | Facilities
Thermo Fisher Opens U.S. Precision Medicine Science Center
Supports development of analytical workflows to generate precise molecular profiles of patients06.12.18
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Celltrion Launches Bio CDMO Business
Initial focus will be placed on autoimmune diseases, breast cancer, blood cancer and cardiovascular diseases06.12.18
-
APIs | Breaking News | Facilities | Industry News | R&D
Cambrex Expands Generic API R&D Capabilities
Will build new R&D lab at its Milan, Italy site06.12.18
-
APIs | Breaking News | Industry News
-
Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Microbiotica, Genentech Announce Collaboration
To discover, develop and commercialize biomarkers, targets and medicines for inflammatory bowel disease06.12.18
